Acción GCAN THE GREATER CANNABIS COMPANY, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas The Greater Cannabis Company, Inc.

Acciones

GCAN

US3916571033

Mercado cerrado - OTC Markets
Otros sitios de cotización
 21:51:08 07/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,0008 USD +6,67 % Gráfico intradía de The Greater Cannabis Company, Inc. +14,29 % -11,11 %
14/05 The Greater Cannabis Company, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
01/04 The Greater Cannabis Company, Inc. informa de los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
GCANRx Featured in American Journal of Endocannabinoid Medicine
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Nanocap Potential Breakout Watchlist (EPAZ, GCAN, IQST, ONCR)
GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt
Greater Cannabis : Change in Certifying Accountants - Form 8-K
GREATER CANNABIS COMPANY, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
Greater Cannabis Company, Inc. Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción GCAN
  4. Noticias The Greater Cannabis Company, Inc.
  5. Otros idiomas